id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-3015-0009,FDA,FDA-2015-N-3015,"Final Transcripts from FDA CDRH re: Public Meeting November 13, 2015",Other,Transcript(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-28T17:57:00Z,,0,0,0900006481dd4b59
FDA-2015-N-3015-0002,FDA,FDA-2015-N-3015,Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants; Public Workshop; Reopening of Comment Period,Notice,Meeting,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,2015-12-25T04:59:59Z,2015-12-24T22:00:48Z,2015-30936,0,0,0900006481d92622
FDA-2015-N-3015-0001,FDA,FDA-2015-N-3015,Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants; Public Workshop; Request for Comments,Notice,Meeting,2015-09-09T04:00:00Z,2015,9,2015-09-09T04:00:00Z,2015-11-26T04:59:59Z,2015-11-25T22:00:59Z,2015-22675,0,0,0900006481c61ab3